Universal children's day--let's improve current interventions to reduce vertical transmission of HIV now.

Early antiretroviral therapy and mortality among HIV-infected infants. N Engl J Med (2008) 17.12

Absence of detectable HIV-1 viremia after treatment cessation in an infant. N Engl J Med (2013) 6.63

Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment. J Virol (1998) 3.16

Early time-limited antiretroviral therapy versus deferred therapy in South African infants infected with HIV: results from the children with HIV early antiretroviral (CHER) randomised trial. Lancet (2013) 2.64

Estimated timing of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission by use of a Markov model. The HIV Infection in Newborns French Collaborative Study Group. Am J Epidemiol (1995) 1.84

Three postpartum antiretroviral regimens to prevent intrapartum HIV infection. N Engl J Med (2012) 1.63

Systematic review of the use of dried blood spots for monitoring HIV viral load and for early infant diagnosis. PLoS One (2014) 1.55

The contribution of maternal HIV seroconversion during late pregnancy and breastfeeding to mother-to-child transmission of HIV. J Acquir Immune Defic Syndr (2012) 1.53

Accurate early infant HIV diagnosis in primary health clinics using a point-of-care nucleic acid test. J Acquir Immune Defic Syndr (2014) 1.52

Excess intrauterine fetal demise associated with maternal human immunodeficiency virus infection. J Infect Dis (1995) 1.30

When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery? AIDS (2012) 1.29

Early initiation of combination antiretroviral therapy in HIV-1-infected newborns can achieve sustained virologic suppression with low frequency of CD4+ T cells carrying HIV in peripheral blood. Clin Infect Dis (2014) 1.22

Performance of HIV-1 DNA or HIV-1 RNA tests for early diagnosis of perinatal HIV-1 infection during anti-retroviral prophylaxis. J Pediatr (2011) 1.21

Post-exposure prophylaxis for SIV revisited: animal model for HIV prevention. AIDS Res Ther (2006) 0.96

Nelfinavir and Lamivudine pharmacokinetics during the first two weeks of life. Pediatr Infect Dis J (2011) 0.92

Use of combination neonatal prophylaxis for the prevention of mother-to-child transmission of HIV infection in European high-risk infants. AIDS (2013) 0.90

Loss of detectability and indeterminate results: Challenges facing HIV infant diagnosis in South Africa's expanding ART programme. S Afr Med J (2014) 0.87